top of page

2024-2025

    1.  "Synthetically developed DNA-targeting naphthalimide-artesunate derivatives and their tumoricidal effect." Indian Patent Granted. No.              506734, 2024

    2. UH Sk,  E Sen, R Roy, A Vartak, S Sharma.  “Naphtalimide-Se-TMZ compound and a method of preparing the same”. Indian Patent                 Application. No. 202431048630 , 2024

    3. S Sharma, R Roy, A Vartak, E Sen, UH Sk*, "Synthesis and characterization of a novel Naphthalimide-Selenium based Temozolomide            drug conjugate in glioma cells". Bioorganic Chemistry, 2025, 154, 107998

    4. D RoyMahapatra, R Singh, UH Sk*, PP Manna, "Engineered artesunate-naphthalimide hybrid dual drug for synergistic multimodal                   therapy against experimental murine lymphoma". Molecular Pharmaceutics 2024, 21 (3), 1090-1107

    5. T Ria, R Roy, US Mandal, UH Sk*, "Prospects of nano-theranostic approaches against breast and cervical cancer". Biochimica et                   Biophysica Acta (BBA)-Reviews on Cancer, 2024, 189227

 

2022-2023

   6. R Roy, T Ria, D RoyMahaPatra, U. H. Sk. Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer, ACS Omega 2023, 8, 19,               16532–16544

   7.  R Singh, U Gupta, P Srivastava, A Paladhi, UH Sk, SK Hira, PP Manna. γc cytokine-aided crosstalk between dendritic cells and natural           killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating  FOXP3 and programmed           cell death protein 1. Cytotherapy 24 (12), 1232-1244, 2022.

   8. N Debabhuti, S Mukherjee, S Neogi, P Sharma, UH Sk, S Maiti, M Poddar  Sarkar, B Tudu, N Bhattacharyya, R Bandyopadhyay.  A                study     of vegetable oil modified QCM sensor to detect β-pinene in Indian cardamom. Talanta, 2022, 236, 122837

   9. U. H. Sk, D RoyMahapatra, S Bhattacharya, Selenium Nanoparticle in the Management of Oxidative Stress During Cancer                              Chemotherapy, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, (P 1-22, 2022)

 10.  U. H. Sk, S Bhattacharya, Oxidative Stress in Cancer, Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 2049-2071, (P             2049-2071, 2022)                                                                                                                                                                                                                 2021

11. P Prasanna, P Kumar, S Mandal, T Payal, S Kumar, U H Sk., P Das, V Ravichandiran, D Mandal. 7,8–dihydroxyflavone functionalized              gold nanoparticles target the arginase enzyme of Leishmania donovani. Nanomedicine. (Accepted) DOI: 10.2217/nnm-2021-0161

12. U. H. Sk *, SK Hira, A Rej, D RoyMahapatra, PP Manna. Development of a PAMAM Dendrimer for Sustained Release of Temozolomide         against Experimental Murine Lymphoma: Assessment of Therapeutic Efficacy. ACS Applied Bio Materials 4 (3), 2628-2638, 2021.

13. S Ghosh, M Basu, K Banerjee, SP Chaudhury, T Paul, DK Bera, DK Pal, UH Sk, CK Panda, A Ghosh. Arsenic level in bladder tumor of          patients from an exposed population: association with progression and prognosis . Future Oncology 17 (11), 1311-1323, 2021

14. U. H. Sk , S. Bhattacharya Selenium as the Magic Bullet, in Book "Handbook of Oxidative Stress and Cancer", Springer Nature                      publication. 2021. Editor: S. Chakraborti et al. (eds.),  Springer Nature publication. 2021                                                                                 2019 Onwards.

15. S Sharma, J Chhimwal, V Patial, U. H. Sk*. Dendrimer-conjugated podophyllotoxin suppresses DENA-induced HCC progression by             modulation of inflammatory and fibrogenic factors. Toxicology Research 8 (4), 560-567, 2019.

16.  A R Patra, S S Roy, A Basu, A Bhuniya, A Bhattacharjee, S Hajraa, UH Sk, R Baral, S Bhattacharyaa. Design and synthesis of coumarin-     based organoselenium as a new hit for myeloprotection and synergistic therapeutic efficacy in adjuvant therapy. Scientific reports. 8(1),           2194, 2018

17.V Patial, S Sharma and U H Sk*. Dendrimer conjugated estramustine nano crystalline ‘DenDot’: An effective inhibitor of DMBA-TPA                induced papilloma formation in mouse. Eur J Pharm Sci., 09, 316-323, 2017

18. D N Karelia, U H Sk, P Singh, A. S. P Gowda, M K. Pandey, S R Ramisetti, S Amin, A K Sharma, Discovery of a Dual Topoisomerase-IIα        and Akt Pathway Inhibitor NISC-6 as Potential Melanoma Therapeutic. Euro J of Med Chem. 2017, 135:282-295

19. UH Sk*, Nanosize dendrimers: potential use as carrier and antimicrobials, ANTIMICROBIAL NANOARCHITECTONICS (ELSEVIER, UK).      Editor: Alexandru Mihai Grumezescu Book Chapter; Invited. 2017, Chapter 12, 323-355

20. C Kojima, UH Sk, D Fukushima, K Irie , N Akazawa, M Umeda, T Niidome. Effect of Main Chain Conformation to Thermosensitivity in            Elastin-Like Peptide-Grafted Polylysine. RSC Advanced. 2015, 5, 104900-104906

21. U H Sk*, V. Patial, S. Sharma. Low toxic synthetic dendrimer conjugated podophyllotoxin nanodevice with potent antitumor activity                against DMBA/TPA induced mouse skin carcinogenesis model. Toxicol Res. 2015, 4, 1204-1213.

22. U H Sk, C Kojima. Dendrimers for theranostic applications. BioMolecular Concepts. 2015, 6(3):205-17 (Review)

23. D Fukushima, UH Sk, Y Sakamoto, I Nakase, C Kojima. Dual Stimuli-Sensitive Dendrimer: Photothermogenic Gold Nanoparticle-Loaded       Thermo-Responsive Elastin-Mimetic Dendrimers. Colloids and Surfaces B: Biointerfaces. 2015, 132,155–160.

24. U H Sk, C Kojima. Dendrimers for Drug Delivery of Anticancer Drugs. Frontiers in Clinical Drug Research- Anti Cancer Agents, Bentham        Science Publishers, Invited Article, Vol. 2, P3-25, 2015.                        2014 Onwards

25. U. H Sk* , D. Dixit, E. Sen. Comparative study of microtubule inhibitors- Estramustine and natural Podophyllotoxin conjugated PAMAM         dendrimer on glioma cell proliferation. Eur J Med Chem. 68, 47-57, August, 2013

26.  U. H. Sk, S. P. Kambhampati, M. K. Mishra, W. G. Lesniak, F. Zhang, R. M. Kannan. Enhancing the Efficacy of Ara-C through                        Conjugation with PAMAM Dendrimer and Linear PEG: A Comparative Study. Biomacromolecules. 14, 3, 801-810, February 2013.

27. J.K.Das, S.Sarkar, U. H. Sk, P. Chakraborty, R. K. Das, S. Bhattacharya. Diphenylmethyl selenocyanate attenuates malachite green              induced oxidative injury through antioxidation and inhibition of DNA damage in mice. Indian J Med Res. 137, 1163-1173, June 2013

28. Y. Cheng, U. H. Sk, Y. Zhang, X. Ren, L. Zhang, K. J. Huber-Keener, Y.-W. Sun, S. Amin,A. K. Sharma, J.-M. Yang. Rational                          incorporation of selenium into temozolomide elicits superior antitumor activity associated with promotion of both apoptotic and autophagic        cell death, PloS One,7, 4, e35104, April, 2012.

29. U. H. Sk, A.S. P. Gowda, J. K. Yun, T. E. Spratt, S. Amin, A. K. Sharma, Development of novel naphthalimide derivatives and their                 evaluation as potential melanoma therapeutics, Eur J Med Chem., 46, 8, 3331-3338, August 2011.

30. J. A. Hengst, X. J. Wang, U. H. Sk, A. K. Sharma, S. Amin, J. K. Yun. Discovery and Evaluation of a Sphingosine Kinase 1 Specific Small     molecule Inhibitor, Bioorg Med Chem Lett. 20, 24, 7498- 7502, Dec., 2010.

31. S. S. Roy, P. Ghosh, U. H. Sk, P. Chakraborty, J. Biswas, A. Bhattacharjee, S. Bhattacharya Naphthalimide based novel organo                     selenocyanates: Finding less toxic forms of selenium that would retain protective efficacy, Bioorg Med Chem Lett. 20, 23, 6951-6955, Dec., 2010 onward....

32.P. Chakraborty, S. S. Roy, U. H. Sk, S. Bhattacharya. Amelioration of cisplatin induced nephrotoxicity in mice by oral administration of            diphenylmethyl selenocyanate, Free Radic Res., 45, 2,177-187, Feb. 2011.

33. P.S. Palkar, M. G. Borland, S. Naruhn, C. H. Ferry, C. Lee, U. H. Sk, A. K. Sharma, S. Amin, I. A. Murray, C. R. Anderson, G. H. Perdew,      F. J. Gonzalez, R. Muller, J. M. Peters, PPARβ/δ-dependent and independent functions of the PPARβ/ δ agonist GSK3787. Mol Phermacol.,    78, 419-430, 2010.

34. K. Sharma, U. H. Sk, P. He, J. Peters, S. Amin, Synthesis of isosteric selenium analog of the PPARβ/ δ- agonist GW501516 and                  comparison of biological activity, Bioorg Med Chem Lett., 20, 14, 4050-4052, July 2010.

35. K. Sharma, U. H. Sk, M. A. Gimbor, J. A. Hengst, X. Wang, J. Yun, S. Amin, Synthesis and bioactivity of sphingosine kinase inhibitors and    their novel aspirinyl conjugated, EurJ Med Chem., 45, 9, 4149-4156, Sept., 2010.

36. U. H. Sk, A. K Sharma, S. Ghosh, S. Bhattacharya, Prevention of cadmium induced oxidative and hepatic damage in mice by a series of      spiro [6-methoxytetralin-1, 3'-pyrrolidine] based organo selenocyanates: Effect of chain length, Eur J Med Chem., 45, 8, 3265-3273, August 2010.

37.  P. Chackraborty, U. H. Sk, N. Murmu, J.K. Das, S. Pal, S. Bhattacharya, Modulation of Cyclophosphamide Induced Cellular Toxicity by        Diphenylmethyl Selenocyanate In Vivo, an Enzymatic Study. J Cancer Mol., 4, 6, 183-189, 2009

38. P. Charaborty, U. H. Sk, S. Bhattacharya, Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide     in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate. Cancer Chemother Pharmacol. 64, 5, 971-980, Oct. 2009.

39. Sarkar, P. Banerjee, U. H. Sk., S. Bhattacharya, S. C Bhattacharya, Role of hydrogen bonding on the spectroscopic properties of                   thiazolidinedione derivatives in homogeneous solvents. Spectrochim Acta A Mol Biomol Spectrosc., 72, 5, 1097-1102, June 2009.

40. R. Tewari, V. Sharma, N. Koul, A. Ghosh, C. Joseph, U. H. Sk, E. Sen., Ebselen abrogates TNFα induced pro-inflammatory response in       glioblastoma. Mol Oncol., 3, 1, 77-83, Feb. 2009.

41. V. Sharma, R. Tewari, U. H. Sk, C. Joseph , E. Sen, Organoselenium Ebselen sensitizes glioblastoma cells to Tumor Necrosis factor             (TNFα) induced apoptosis through two distinct pathways involving NF-ĸB downregulation and Fas-mediated formation of death inducing          signaling complex, Int J Cancer., 123, 9, 2204-2212, Nov. 2008.

42. U. H. Sk.,S. Bhattacharya, Synthesis of O-prenylated and O-geranylated derivatives of 5- benzylidene2,4-thiazolidinediones and                   evaluation of their free radical scavenging activity as well as effect on some phase II antioxidant/detoxifying enzymes, Bioorg Med Chem           Lett., 17, 5, 1149-1154, March, 2007.

43. R. K. Das, U. H. Sk.,S. Bhattacharya, Protective Effect of Diphenylmethyl selenocyanate against CCl4-induced hepatic injury, J Appl              Toxicol., 27, 6, 527-537, Nov. 2007.

44. P. Banerjee, S. Chatterjee, S. Pramanik, U. H. Sk.,S. Bhattacharya, S. C, Bhattacharya, Spectroscopic studies of 2-(2-bromo-ethyl)-6-           nitro-benzo[de]isoquinolene -1,3-dione in water/alkanol mixed solvents and nonionic micelle of Igepal CO series, Spectrochim Acta A Mol      Biomol Spectrosc., 66, 4-5, 1110-1114, April, 2007.

45. S. Chatterjee, S. Pramanik, U. H. Sk.,S. Bhattacharya, S. C. Bhattacharya, Synthesis and Photoinduced intramolecular charge transfer of     N-substituted1,8-Naphthalimide derivatives in homogeneous solvents and in presence of reduced glutathione. J Photochem Photobiol A         Chem., 187, 1,64-71, March, 2007.

46. U. H. Sk, S. Bhattacharya, Prevention of cadmium induced lipid peroxidation, depletion of some antioxidative enzymes and glutathione         by a series of novel organoselenocyanates, EnvironToxicol Pharmacol., 22, 3, 298-308, Nov., 2006.

47.U. H. Sk.,S. Sengupta, S. Bhattacharya, Synthesis and evaluation of antioxidative properties of a series of organoselenium compounds,       Bioorg Med Chem., 13, 20, 5750-5758, Oct., 2005.

48. R. K. Das, U. H. Sk,S. Bhattacharya, Diphenylmethyl selenocyanate inhibits DMBAcroton oil induced two-stage mouse skin                           carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation Cancer Lett., 230, 1, 90-101, Dec. 2005.

49. S. K. Ghosh, U. H. Sk.,S. Bhattacharya, S. C. Bhattacharya, 2-(2-Selenocyanic acid ethyl ester)-1H-benz[de] isoquinoline-1,3-(2H)-dione,     synthesis photophysics and interaction with bovine serum albumin: A spectroscopic approach J Photochem Photobiol B: Biol., 81, 2, 121-       128, Nov. 2005.

bottom of page